Facts & Figures

Selected key financial figures

In EUR mio.	2025	2024	2023
Revenues	7,69	4,75	9,06
Operating result	18,67	-7,60	-5,00
Loss for the year	18,02	-15,42	-6,37
Cash and cash equivalents per 31.12.	0,95	1,71	2,56
Balance sheet total per 31.12.	5,95	8,18	12,36
Net cash flow	-0,8	-0,9	-5,6

Tobias Meister

Investor Relations

ir@marinomed.com

Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg, Austria
+43 2262 90300
office@marinomed.com